TY - JOUR
T1 - Dry eye disease in axial spondyloarthritis
T2 - heterogeneous ocular surface dysfunction involving tear film instability and tear production from the AIDA network registry
AU - Caggiano, Valeria
AU - Vitale, Antonio
AU - Sbalchiero, Jessica
AU - Tufan, Abdurrahman
AU - Guaracha-Basañez, Guillermo Arturo
AU - Kawakami-Campos, Perla Ayumi
AU - Hinojosa-Azaola, Andrea
AU - Duran, Rahime
AU - Kucuk, Hamit
AU - Ragab, Gaafar
AU - Ruscitti, Piero
AU - Lopalco, Giuseppe
AU - Karamanakos, Anastasios
AU - Fotis, Lampros
AU - Ghanema, Mahmoud
AU - Cipriani, Paola
AU - Morrone, Maria
AU - Dimouli, Aikaterini
AU - Kourtesi, Katerina
AU - Tharwat, Samar
AU - Moshrif, Abdelhfeez
AU - Sota, Jurgen
AU - Mayo-Juanatey, Adrián
AU - Boyarchuk, Oksana
AU - Edrees, Amr
AU - Barone, Patrizia
AU - Carubbi, Francesco
AU - Chimenti, Maria Sole
AU - Conforti, Alessandro
AU - Thabet, Maissa
AU - Opris-Belinski, Daniela
AU - Erten, Şükran
AU - Hegazy, Mohamed Tharwat
AU - Mazzei, Maria Antonietta
AU - Piscitello, Chiara
AU - Frediani, Bruno
AU - Balistreri, Alberto
AU - Cifuentes-González, Carlos
AU - de-la-Torre, Alejandra
AU - Cantarini, Luca
AU - Fabiani, Claudia
N1 - Publisher Copyright:
© 2026 Caggiano, Vitale, Sbalchiero, Tufan, Guaracha-Basañez, Kawakami-Campos, Hinojosa-Azaola, Duran, Kucuk, Ragab, Ruscitti, Lopalco, Karamanakos, Fotis, Ghanema, Cipriani, Morrone, Dimouli, Kourtesi, Tharwat, Moshrif, Sota, Mayo-Juanatey, Boyarchuk, Edrees, Barone, Carubbi, Chimenti, Conforti, Thabet, Opris-Belinski, Erten, Hegazy, Mazzei, Piscitello, Frediani, Balistreri, Cifuentes-González, de-la-Torre, Cantarini and Fabiani.
PY - 2026/8
Y1 - 2026/8
N2 - Objective – Dry eye disease (DED) has been described in axial spondyloarthritis (axSpA), but patterns of tear fluid and ocular surface involvement remain incompletely characterized. This study aims to evaluate tear film instability and tear production in axSpA and explore the heterogeneity of DED manifestations. Methods – Axial spondyloarthritis patients and healthy controls underwent non-invasive tear break-up time (niTBUT), Schirmer test, and Ocular Surface Disease Index (OSDI)- 6 evaluation. Group differences were assessed using niTBUT thresholds (<10 s and <5 s). Results – Mean niTBUT was significantly lower in axSpA patients than controls (7.85 ± 5.63 vs. 10.61 ± 5.27 s; p < 0.001); niTBUT <5 s, but not <10 s, differentiated groups (p = 0.003 and p = 0.105, respectively). ROC analysis identified an optimal niTBUT cut-off of 5.15 s. Schirmer values also discriminated axSpA patients from controls, with an optimal threshold of 4.5 mm. Agreement between niTBUT and Schirmer classification was weak (Cohen κ = 0.18). OSDI-6 scores were not significantly associated with pathological niTBUT. The niTBUT values were significantly associated with patients' age, but the diagnosis of axSpA accounted for the main determinant of niTBUT <5 s (likelihood ratio test, p = 0.026). Conclusion – Within the present cohort, a niTBUT <5 s showed greater discriminative performance than the conventional 10-s cut-off and may identify a subgroup of axSpA patients with more severe tear film instability. Aging contributes to tear film instability, but axSpA independently contributes to severe niTBUT impairment. Tear film instability and reduced tear secretion are both involved in DED affecting axSpA patients.
AB - Objective – Dry eye disease (DED) has been described in axial spondyloarthritis (axSpA), but patterns of tear fluid and ocular surface involvement remain incompletely characterized. This study aims to evaluate tear film instability and tear production in axSpA and explore the heterogeneity of DED manifestations. Methods – Axial spondyloarthritis patients and healthy controls underwent non-invasive tear break-up time (niTBUT), Schirmer test, and Ocular Surface Disease Index (OSDI)- 6 evaluation. Group differences were assessed using niTBUT thresholds (<10 s and <5 s). Results – Mean niTBUT was significantly lower in axSpA patients than controls (7.85 ± 5.63 vs. 10.61 ± 5.27 s; p < 0.001); niTBUT <5 s, but not <10 s, differentiated groups (p = 0.003 and p = 0.105, respectively). ROC analysis identified an optimal niTBUT cut-off of 5.15 s. Schirmer values also discriminated axSpA patients from controls, with an optimal threshold of 4.5 mm. Agreement between niTBUT and Schirmer classification was weak (Cohen κ = 0.18). OSDI-6 scores were not significantly associated with pathological niTBUT. The niTBUT values were significantly associated with patients' age, but the diagnosis of axSpA accounted for the main determinant of niTBUT <5 s (likelihood ratio test, p = 0.026). Conclusion – Within the present cohort, a niTBUT <5 s showed greater discriminative performance than the conventional 10-s cut-off and may identify a subgroup of axSpA patients with more severe tear film instability. Aging contributes to tear film instability, but axSpA independently contributes to severe niTBUT impairment. Tear film instability and reduced tear secretion are both involved in DED affecting axSpA patients.
UR - https://www.scopus.com/pages/publications/105047827529
UR - https://www.scopus.com/pages/publications/105047827529#tab=citedBy
U2 - 10.3389/fmed.2026.1851512
DO - 10.3389/fmed.2026.1851512
M3 - Research Article
C2 - 42609628
AN - SCOPUS:105047827529
SN - 2296-858X
VL - 13
SP - 1
EP - 9
JO - Frontiers in Medicine
JF - Frontiers in Medicine
M1 - 1851512
ER -